There are 2789 resources available
478P - TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment
Presenter: Cristina Santos
Session: ePoster Display
479P - Difference gene mutations among CRC patients with MSS and MSI-H types in China
Presenter: Jianjun Yang
Session: ePoster Display
480P - Gene expression of NANOG and NANOGP8 in colorectal cancer
Presenter: Hiroyuki Arai
Session: ePoster Display
481P - Evaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer
Presenter: Romain Chautard
Session: ePoster Display
458P - Circulating tumor DNA analysis predicting recurrence risk in patients with stage I-III colorectal cancer
Presenter: Jin Gu
Session: ePoster Display
459P - Dynamic changes of pro-angiogenic factors during FOLFIRI-aflibercept treatment: Interim analysis of DISTINCTIVE trial
Presenter: Eleonora Lai
Session: ePoster Display
460P - Somatic second hit increases the instability of genome in Chinese colorectal cancer patients
Presenter: Jing Gao
Session: ePoster Display
461P - Molecular tumor profiling and matched molecular targeted treatment in metastatic young-onset colorectal cancer (YOCR)
Presenter: Iosune Baraibar Argota
Session: ePoster Display
462P - Heterogeneity of mismatch repair status between primary tumors and matched metastases in metastatic colorectal cancer
Presenter: David Tougeron
Session: ePoster Display
490P - New horizons in metastatic colorectal cancer: Role of CD44 expression
Presenter: Pina Ziranu
Session: ePoster Display